|
G |
Actn2 |
actinin alpha 2 |
decreases expression |
ISO |
Ribavirin results in decreased expression of ACTN2 protein |
CTD |
PMID:32112805 |
|
NCBI chr17:58,143,334...58,210,622
Ensembl chr17:58,142,625...58,210,622
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases phosphorylation |
ISO |
Ribavirin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:29112301 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Carm1 |
coactivator-associated arginine methyltransferase 1 |
multiple interactions decreases expression |
ISO |
Ribavirin inhibits the reaction [CARM1 protein binds to EIF4E promoter]; Ribavirin inhibits the reaction [CARM1 protein binds to VEGFA promoter] Ribavirin results in decreased expression of CARM1 protein |
CTD |
PMID:34919946 |
|
NCBI chr 8:20,097,262...20,141,950
Ensembl chr 8:20,097,254...20,147,689
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
ISO |
Ribavirin results in increased activity of CASP3 protein Ribavirin promotes the reaction [FAS protein results in increased activity of CASP3 protein] |
CTD |
PMID:12760867 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
multiple interactions |
ISO |
Ribavirin promotes the reaction [FAS protein results in increased activity of CASP7 protein] |
CTD |
PMID:12760867 |
|
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
Ribavirin promotes the reaction [FAS protein results in increased activity of CASP8 protein] |
CTD |
PMID:12760867 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
Ribavirin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein] |
CTD |
PMID:36416909 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
ISO |
Ribavirin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein] |
CTD |
PMID:36416909 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccna2 |
cyclin A2 |
decreases expression |
ISO |
Ribavirin results in decreased expression of CCNA2 protein |
CTD |
PMID:33577917 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
decreases expression |
ISO |
Ribavirin results in decreased expression of CCND1 protein |
CTD |
PMID:29112301 PMID:33577917 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
decreases expression |
ISO |
Ribavirin results in decreased expression of CCNE1 protein |
CTD |
PMID:33577917 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
multiple interactions decreases phosphorylation decreases expression |
ISO |
Ribavirin inhibits the reaction [CARM1 protein binds to EIF4E promoter]; Ribavirin inhibits the reaction [Doxorubicin results in increased phosphorylation of EIF4E protein] Ribavirin results in decreased phosphorylation of EIF4E protein Ribavirin results in decreased expression of EIF4E mRNA; Ribavirin results in decreased expression of EIF4E protein |
CTD |
PMID:29112301 PMID:33577917 PMID:34919946 |
|
NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683
|
|
G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
decreases phosphorylation |
ISO |
Ribavirin results in decreased phosphorylation of EIF4EBP1 protein |
CTD |
PMID:29112301 |
|
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
|
|
G |
Epo |
erythropoietin |
multiple interactions increases expression |
ISO |
[peginterferon alfa-2b co-treated with Ribavirin] affects the expression of EPO protein; [Ribavirin co-treated with Interferons] results in increased expression of EPO protein Ribavirin results in increased expression of EPO |
CTD |
PMID:12713065 PMID:15232364 PMID:20009130 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Fas |
Fas cell surface death receptor |
multiple interactions |
ISO |
Ribavirin promotes the reaction [FAS protein results in increased activity of CASP3 protein]; Ribavirin promotes the reaction [FAS protein results in increased activity of CASP7 protein]; Ribavirin promotes the reaction [FAS protein results in increased activity of CASP8 protein] |
CTD |
PMID:12760867 |
|
NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591
|
|
G |
Gas5 |
growth arrest specific 5 |
increases expression |
ISO |
Ribavirin results in increased expression of GAS5 mRNA |
CTD |
PMID:32112805 |
|
NCBI chr13:73,303,611...73,306,932
|
|
G |
Gata4 |
GATA binding protein 4 |
decreases expression |
ISO |
Ribavirin results in decreased expression of GATA4 mRNA |
CTD |
PMID:32112805 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
H2ax |
H2A.X variant histone |
increases expression |
ISO |
Ribavirin results in increased expression of H2AX protein modified form |
CTD |
PMID:32112805 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
decreases expression |
ISO |
Ribavirin results in decreased expression of ICAM1 protein modified form |
CTD |
PMID:12853993 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression increases expression |
ISO |
[Ribavirin co-treated with IFNA2 protein] affects the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]; [Ribavirin co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IFNG mRNA; Ribavirin inhibits the reaction [Lipopolysaccharides results in increased secretion of IFNG protein]; Ribavirin results in increased expression of and results in increased secretion of IFNG protein Ribavirin results in decreased expression of IFNG mRNA Ribavirin results in increased expression of IFNG mRNA; Ribavirin results in increased expression of IFNG protein |
CTD |
PMID:9722937 PMID:10190717 PMID:10770762 PMID:17210188 PMID:29594315 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Ifnl3 |
interferon, lambda 3 |
multiple interactions |
ISO |
IFNL3 gene polymorphism affects the susceptibility to [Ribavirin co-treated with IFNA2 protein modified form]; IFNL3 gene SNP affects the susceptibility to [peginterferon alfa-2a co-treated with Ribavirin]; IFNL3 protein results in increased susceptibility to [Ribavirin co-treated with IFNA2 protein modified form] |
CTD |
PMID:19749757 PMID:19749758 PMID:22003405 |
|
NCBI chr 1:83,814,456...83,816,096
Ensembl chr 1:83,814,564...83,816,096
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases expression |
ISO EXP |
[Ribavirin co-treated with IFNA2 protein] affects the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]; Ribavirin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein]; Ribavirin results in decreased expression of and results in decreased secretion of IL10 protein Ribavirin results in decreased expression of IL10 mRNA Ribavirin results in decreased expression of IL10 protein [peginterferon alfa-2a co-treated with Ribavirin co-treated with Danazol] results in decreased expression of IL10 mRNA; [peginterferon alfa-2a co-treated with Ribavirin] results in increased expression of IL10 mRNA |
CTD |
PMID:9722937 PMID:10190717 PMID:10770762 PMID:17210188 PMID:18007553 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il12a |
interleukin 12A |
multiple interactions |
ISO |
[Ribavirin co-treated with IFNA2 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]]; Ribavirin promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:9722937 |
|
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
|
|
G |
Il12b |
interleukin 12B |
multiple interactions |
ISO |
[Ribavirin co-treated with IFNA2 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]]; Ribavirin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]; Ribavirin promotes the reaction [Lipopolysaccharides results in increased secretion of [IL12A protein binds to IL12B protein]] |
CTD |
PMID:9722937 PMID:36416909 |
|
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions increases expression |
ISO |
Ribavirin inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] Ribavirin results in increased expression of IL1B mRNA |
CTD |
PMID:9722937 PMID:29594315 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions increases expression |
ISO |
[Ribavirin co-treated with IFNA2 protein] promotes the reaction [Lipopolysaccharides results in increased secretion of IL2 protein]; [Ribavirin co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL2 mRNA; Ribavirin promotes the reaction [Lipopolysaccharides results in increased secretion of IL2 protein]; Ribavirin results in increased expression of and results in increased secretion of IL2 protein Ribavirin results in increased expression of IL2 protein Ribavirin results in increased expression of IL2 mRNA; Ribavirin results in increased expression of IL2 protein |
CTD |
PMID:9722937 PMID:10190717 PMID:10770762 PMID:29594315 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
decreases expression multiple interactions |
ISO |
Ribavirin results in decreased expression of IL4 mRNA; Ribavirin results in decreased expression of IL4 protein Ribavirin promotes the reaction [Lipopolysaccharides results in increased secretion of IL4 protein]; Ribavirin results in decreased expression of and results in decreased secretion of IL4 protein |
CTD |
PMID:9722937 PMID:10190717 PMID:10770762 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
decreases expression multiple interactions |
ISO |
Ribavirin results in decreased expression of IL5 mRNA; Ribavirin results in decreased expression of IL5 protein Ribavirin results in decreased expression of and results in decreased secretion of IL5 protein |
CTD |
PMID:10190717 PMID:10770762 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP |
[peginterferon alfa-2a co-treated with Ribavirin co-treated with Danazol] results in decreased expression of IL6 mRNA |
CTD |
PMID:18007553 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Isl1 |
ISL LIM homeobox 1 |
decreases expression |
ISO |
Ribavirin results in decreased expression of ISL1 mRNA |
CTD |
PMID:32112805 |
|
NCBI chr 2:48,079,412...48,090,704
Ensembl chr 2:48,080,522...48,095,584
|
|
G |
Itpa |
inosine triphosphatase |
increases response to substance |
ISO |
ITPA 5' UTR SNP results in increased susceptibility to Ribavirin |
CTD |
PMID:20637204 |
|
NCBI chr 3:117,885,464...117,897,247
Ensembl chr 3:117,885,099...117,897,249
|
|
G |
Klrc1 |
killer cell lectin like receptor C1 |
affects expression |
ISO |
Ribavirin co-treated with Interferon alfa-2a affects expression of KLRC1 protein in Natural Killer cells |
RGD |
PMID:20550548 |
RGD:40818079 |
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
decreases phosphorylation |
ISO |
Ribavirin results in decreased phosphorylation of MTOR protein |
CTD |
PMID:29112301 |
|
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Ribavirin results in decreased expression of MYC protein |
CTD |
PMID:29112301 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh6 |
myosin heavy chain 6 |
decreases expression |
ISO |
Ribavirin results in decreased expression of MYH6 mRNA |
CTD |
PMID:32112805 |
|
NCBI chr15:28,418,120...28,442,316
Ensembl chr15:28,417,616...28,441,720
|
|
G |
Oas1a |
2'-5' oligoadenylate synthetase 1A |
multiple interactions |
ISO |
[Ribavirin co-treated with IFNA2 protein] results in increased activity of OAS1 protein |
CTD |
PMID:9722937 |
|
NCBI chr12:35,669,798...35,680,505
Ensembl chr12:35,669,801...35,680,517
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Ribavirin results in decreased expression of PCNA protein |
CTD |
PMID:33577917 PMID:34919946 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Prmt1 |
protein arginine methyltransferase 1 |
affects expression |
ISO |
Ribavirin affects the expression of PRMT1 protein |
CTD |
PMID:34919946 |
|
NCBI chr 1:95,458,853...95,468,176
Ensembl chr 1:95,458,850...95,468,345
|
|
G |
Prmt2 |
protein arginine methyltransferase 2 |
decreases expression |
ISO |
Ribavirin results in decreased expression of PRMT2 protein |
CTD |
PMID:34919946 |
|
NCBI chr20:12,394,748...12,420,643
Ensembl chr20:12,394,798...12,420,643
|
|
G |
Prmt3 |
protein arginine methyltransferase 3 |
decreases expression |
ISO |
Ribavirin results in decreased expression of PRMT3 protein |
CTD |
PMID:34919946 |
|
NCBI chr 1:99,492,712...99,581,774
Ensembl chr 1:99,492,724...99,579,435
|
|
G |
Prmt5 |
protein arginine methyltransferase 5 |
decreases expression |
ISO |
Ribavirin results in decreased expression of PRMT5 protein |
CTD |
PMID:33577917 PMID:34919946 |
|
NCBI chr15:27,968,893...27,978,291
Ensembl chr15:27,968,910...27,978,296
|
|
G |
Prmt6 |
protein arginine methyltransferase 6 |
affects expression |
ISO |
Ribavirin affects the expression of PRMT6 protein |
CTD |
PMID:34919946 |
|
NCBI chr 2:197,927,750...197,932,760
Ensembl chr 2:197,927,220...197,933,648
|
|
G |
Prmt7 |
protein arginine methyltransferase 7 |
decreases expression |
ISO |
Ribavirin results in decreased expression of PRMT7 protein |
CTD |
PMID:33577917 PMID:34919946 |
|
NCBI chr19:34,110,724...34,161,531
Ensembl chr19:34,110,747...34,162,577
|
|
G |
Prmt8 |
protein arginine methyltransferase 8 |
decreases expression |
ISO |
Ribavirin results in decreased expression of PRMT8 protein |
CTD |
PMID:34919946 |
|
NCBI chr 4:160,535,813...160,618,193
Ensembl chr 4:160,535,813...160,617,930
|
|
G |
Slc29a1 |
solute carrier family 29 member 1 |
increases uptake |
ISO |
SLC29A1 protein results in increased uptake of Ribavirin |
CTD |
PMID:20185188 |
|
NCBI chr 9:15,399,661...15,414,203
Ensembl chr 9:15,399,612...15,414,203
|
|
G |
Slc29a3 |
solute carrier family 29 member 3 |
affects transport |
ISO |
SLC29A3 protein affects the transport of Ribavirin |
CTD |
PMID:19164483 |
|
NCBI chr20:28,645,265...28,685,388
Ensembl chr20:28,647,391...28,685,388
|
|
G |
Slc6a4 |
solute carrier family 6 member 4 |
multiple interactions increases expression |
ISO |
Ribavirin promotes the reaction [SLC6A4 protein results in increased uptake of Serotonin]; Ribavirin results in increased expression of and results in increased activity of SLC6A4 protein Ribavirin results in increased expression of SLC6A4 mRNA |
CTD |
PMID:16476009 |
|
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
ISO EXP |
Ribavirin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; Ribavirin results in increased expression of and results in increased secretion of TNF protein Ribavirin results in increased expression of TNF mRNA; Ribavirin results in increased expression of TNF protein [peginterferon alfa-2a co-treated with Ribavirin co-treated with Danazol] results in decreased expression of TNF mRNA |
CTD |
PMID:9722937 PMID:10190717 PMID:10770762 PMID:18007553 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases response to substance |
ISO |
Ribavirin results in decreased susceptibility to TNFSF10 protein |
CTD |
PMID:12637521 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tnnt2 |
troponin T2, cardiac type |
decreases expression |
ISO |
Ribavirin results in decreased expression of TNNT2 protein |
CTD |
PMID:32112805 |
|
NCBI chr13:47,267,325...47,285,390
Ensembl chr13:47,267,204...47,285,388
|
|
G |
Tp53 |
tumor protein p53 |
increases expression affects activity |
ISO |
Ribavirin results in increased expression of TP53 protein Ribavirin results in increased expression of TRP53 protein Ribavirin affects the activity of TP53 protein |
CTD |
PMID:32112805 PMID:33577917 PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txn1 |
thioredoxin 1 |
decreases expression |
ISO |
Ribavirin results in decreased expression of TXN protein |
CTD |
PMID:16198661 |
|
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression multiple interactions decreases secretion |
ISO |
Ribavirin results in decreased expression of VEGFA mRNA; Ribavirin results in decreased expression of VEGFA protein Ribavirin inhibits the reaction [CARM1 protein binds to VEGFA promoter] Ribavirin results in decreased secretion of VEGFA protein |
CTD |
PMID:29112301 PMID:34919946 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|